Annual Retained Earnings
-$653.70 M
-$214.53 M-48.85%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual retained earnings is currently -$653.70 million, with the most recent change of -$214.53 million (-48.85%) on 31 December 2023. During the last 3 years, it has fallen by -$378.45 million (-137.49%). CRNX annual retained earnings is now -9096.71% below its all-time high of -$7.11 million, reached on 31 December 2016.CRNX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$871.51 M
-$76.83 M-9.67%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly retained earnings is currently -$871.51 million, with the most recent change of -$76.83 million (-9.67%) on 30 September 2024. Over the past year, it has dropped by -$217.81 million (-33.32%). CRNX quarterly retained earnings is now -5258.22% below its all-time high of -$16.27 million, reached on 31 December 2017.CRNX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -33.3% |
| 3 y3 years | -137.5% | -216.6% |
| 5 y5 years | -596.9% | -829.1% |
CRNX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -137.5% | at low | -216.6% | at low |
| 5 y | 5 years | -596.9% | at low | -829.1% | at low |
| alltime | all time | -9096.7% | at low | -5258.2% | at low |
Crinetics Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$871.51 M(+9.7%) |
| June 2024 | - | -$794.69 M(+10.3%) |
| Mar 2024 | - | -$720.63 M(+10.2%) |
| Dec 2023 | -$653.70 M(+48.8%) | -$653.70 M(+10.1%) |
| Sept 2023 | - | -$593.61 M(+10.7%) |
| June 2023 | - | -$536.15 M(+10.5%) |
| Mar 2023 | - | -$485.17 M(+10.5%) |
| Dec 2022 | -$439.17 M(+59.6%) | -$439.17 M(+11.4%) |
| Sept 2022 | - | -$394.18 M(+11.9%) |
| June 2022 | - | -$352.26 M(+13.7%) |
| Mar 2022 | - | -$309.88 M(+12.6%) |
| Dec 2021 | -$275.25 M | -$275.25 M(+12.6%) |
| Sept 2021 | - | -$244.46 M(+12.9%) |
| June 2021 | - | -$216.61 M(+13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -$190.51 M(+13.7%) |
| Dec 2020 | -$167.61 M(+78.7%) | -$167.61 M(+14.8%) |
| Sept 2020 | - | -$145.97 M(+14.4%) |
| June 2020 | - | -$127.65 M(+14.8%) |
| Mar 2020 | - | -$111.16 M(+18.5%) |
| Dec 2019 | -$93.80 M(+116.2%) | -$93.80 M(+18.4%) |
| Sept 2019 | - | -$79.25 M(+22.3%) |
| June 2019 | - | -$64.82 M(+23.7%) |
| Mar 2019 | - | -$52.40 M(+20.8%) |
| Dec 2018 | -$43.38 M(+166.7%) | -$43.38 M(+24.4%) |
| Sept 2018 | - | -$34.88 M(+27.8%) |
| June 2018 | - | -$27.30 M(+25.6%) |
| Mar 2018 | - | -$21.73 M(+33.6%) |
| Dec 2017 | -$16.27 M(+128.8%) | -$16.27 M |
| Dec 2016 | -$7.11 M | - |
FAQ
- What is Crinetics Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly retained earnings year-on-year change?
What is Crinetics Pharmaceuticals annual retained earnings?
The current annual retained earnings of CRNX is -$653.70 M
What is the all time high annual retained earnings for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual retained earnings is -$7.11 M
What is Crinetics Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of CRNX is -$871.51 M
What is the all time high quarterly retained earnings for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly retained earnings is -$16.27 M
What is Crinetics Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, CRNX quarterly retained earnings has changed by -$217.81 M (-33.32%)